269 related articles for article (PubMed ID: 22546421)
1. Uterine smooth muscle tumors of uncertain malignant potential: diagnostic challenges and therapeutic dilemmas. Report of 2 cases and review of the literature.
Vilos GA; Marks J; Ettler HC; Vilos AG; Prefontaine M; Abu-Rafea B
J Minim Invasive Gynecol; 2012; 19(3):288-95. PubMed ID: 22546421
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
3. ["STUMP" (smooth muscle tumour of uncertain malignant potential), a tumour of the uterus in pregnancy--a diagnostic and therapeutic challenge].
Clauss S; Höller S; Hegi L; Blum R; Hösli I
Z Geburtshilfe Neonatol; 2010 Apr; 214(2):74-7. PubMed ID: 20411475
[TBL] [Abstract][Full Text] [Related]
4. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
Ip PP; Tse KY; Tam KF
Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
[TBL] [Abstract][Full Text] [Related]
5. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings.
Tanaka YO; Nishida M; Tsunoda H; Okamoto Y; Yoshikawa H
J Magn Reson Imaging; 2004 Dec; 20(6):998-1007. PubMed ID: 15558559
[TBL] [Abstract][Full Text] [Related]
6. CD147 expression in uterine smooth muscle tumors, and its potential role as a diagnostic and prognostic marker in patients with leiomyosarcoma.
Ozler A; Evsen MS; Turgut A; Sak ME; Tunc SY; Agacayak E; Alabalik U; Basaranoglu S; Keles AN; Gul T
J Exp Ther Oncol; 2014; 10(4):325-30. PubMed ID: 25509988
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
[TBL] [Abstract][Full Text] [Related]
8. The Clinicopathological Study of 21 Cases With Uterine Smooth Muscle Tumors of Uncertain Malignant Potential: Centralized Review Can Purify the Diagnosis.
Basaran D; Usubutun A; Salman MC; Narin MA; Boyraz G; Turkmen O; Comert Kimyon G; Karalok A; Bulbul D; Turan T; Ozgul N; Yuce K
Int J Gynecol Cancer; 2018 Feb; 28(2):233-240. PubMed ID: 29303932
[TBL] [Abstract][Full Text] [Related]
9. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors.
Fadare O; Liang SX
Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203
[TBL] [Abstract][Full Text] [Related]
10. Fascin expression in uterine smooth muscle tumors.
Kefeli M; Yildiz L; Kaya FC; Aydin O; Kandemir B
Int J Gynecol Pathol; 2009 Jul; 28(4):328-33. PubMed ID: 19483633
[TBL] [Abstract][Full Text] [Related]
11. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
Giuntoli RL; Gostout BS; DiMarco CS; Metzinger DS; Keeney GL
J Reprod Med; 2007 Nov; 52(11):1001-10. PubMed ID: 18161397
[TBL] [Abstract][Full Text] [Related]
13. Smooth Muscle Tumors of the Female Genital Tract.
Devereaux KA; Schoolmeester JK
Surg Pathol Clin; 2019 Jun; 12(2):397-455. PubMed ID: 31097110
[TBL] [Abstract][Full Text] [Related]
14. [Uterine smooth muscle tumors--determination of clinical behavior and classification].
Gincheva D; Nikolova M; Gorchev G; Tomov S
Akush Ginekol (Sofiia); 2014; 53(4):40-6. PubMed ID: 25510070
[TBL] [Abstract][Full Text] [Related]
15. Clinical update of smooth muscle tumors of the uterus.
Solomon LA; Schimp VL; Ali-Fehmi R; Diamond MP; Munkarah AR
J Minim Invasive Gynecol; 2005; 12(5):401-8. PubMed ID: 16213425
[TBL] [Abstract][Full Text] [Related]
16. Uterine smooth-muscle tumors with unusual growth patterns.
Vaquero ME; Magrina JF; Leslie KO
J Minim Invasive Gynecol; 2009; 16(3):263-8. PubMed ID: 19423058
[TBL] [Abstract][Full Text] [Related]
17. POTENTIAL LIFE PROGNOSTIC MARKER FOR MESENCHYMAL TUMOR RESEMBLING UTERINE LEIOMYOSARCOMA.
Nishikawa S; Hayashi T; Uzaki T; Yaegashi N; Abiko K; Konishi I
Georgian Med News; 2023 Oct; (343):119-126. PubMed ID: 38096528
[TBL] [Abstract][Full Text] [Related]
18. Malignant mesenchymal tumors of the uterus - time to advocate a genetic classification.
Rommel B; Holzmann C; Bullerdiek J
Expert Rev Anticancer Ther; 2016 Nov; 16(11):1155-1166. PubMed ID: 27602604
[TBL] [Abstract][Full Text] [Related]
19. [Uterine fibroid associated with smooth muscle tumor of uncertain malignant potential (STUMP): about a case].
Saoud MK; Benchiba I; Mamouni N; Errarhay S; Bouchikhi C; Banani A
Pan Afr Med J; 2018; 31():151. PubMed ID: 31086612
[TBL] [Abstract][Full Text] [Related]
20. Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.
Croce S; Ducoulombier A; Ribeiro A; Lesluyes T; Noel JC; Amant F; Guillou L; Stoeckle E; Devouassoux-Shisheboran M; Penel N; Floquet A; Arnould L; Guyon F; Mishellany F; Chakiba C; Cuppens T; Zikan M; Leroux A; Frouin E; Farre I; Genestie C; Valo I; MacGrogan G; Chibon F
Mod Pathol; 2018 May; 31(5):816-828. PubMed ID: 29327710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
